. 2016 Jul 5;94(10):718–727. doi: 10.2471/BLT.15.160044

Table 4. Projected number of lives saved due to a hypothetical package of measles vaccine with a set of additional maternal and child health interventions during the measles supplementary immunization activity, India 2010–2013.

Compliance scenario and state
	Due to specific intervention^a							Not attributable to specific intervention			Total
	Measles vaccine	Bednets	Zinc	Complementary feeding	Micronutrients	Vitamin A	Calcium^b	Diarrhoea	Pneumonia	Measles	Total
By state (70% scenario)
Assam	365	3 611	810	254	149	131	16	121	93	31	5 581
Bihar	3 265	3 981	3 030	1 076	595	415	43	417	421	169	13 412
Chhattisgarh	76	1 691	301	123	126	41	10	33	56	8	2 465
Gujarat	256	733	677	156	250	107	11	63	75	53	2 381
Haryana	421	374	246	61	122	50	5	23	19	15	1 336
Jharkhand	338	2 945	773	192	172	101	13	92	100	24	4 750
Madhya Pradesh	1 791	4 240	2 163	532	499	264	28	234	301	97	10 149
Manipur	31	177	62	42	12	8	1	46	53	35	467
Meghalaya	32	180	82	9	14	10	1	48	56	35	467
Rajasthan	962	2 256	1 604	268	479	175	34	95	204	41	6 118
Tripura	27	206	69	9	10	10	1	4	6	1	343
Uttar Pradesh	10 671	4 539	5 712	1 562	1 333	781	108	662	643	449	26 460
All states
70% scenario	18 235	24 933	15 529	4 284	3 761	2 093	271	1 838	2 027	958	73 929
50% scenario	18 314	24 929	13 346	4 292	2 687	2 109	196	1 647	1 806	829	70 155
90% scenario	18 159	24 934	19 849	4 235	4 838	2 080	350	1 870	2 061	945	79 321

^a Lives saved due to the intervention listed in the column header.

^b These are maternal deaths; all other deaths represent children younger than 5 years.

^c Additional lives saved due to prevention of disease (not intervention-specific).

Note: Including 12 states participating in India’s 2010–2013 measles supplementary immunization activity. Analyses use proportional mortality from the Million Deaths Study²² and vitamin A effectiveness from the Deworming and Enhanced Vitamin A Trial.²¹ Lives saved were calculated for the period 2010–2013. Compliance figures apply to multiple micronutrients and calcium for pregnant women, and preventive zinc for children; compliance scenarios are outlined in Table 2.